Cipro and Darzalex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Darzalex (daratumumab). Common drug interactions include white blood cell count decreased among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Darzalex. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Darzalex?

Darzalex has active ingredients of daratumumab. eHealthMe is studying from 20,206 Darzalex users. Check the latest studies of Darzalex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

28 people who take Cipro and Darzalex together, and have interactions are studied.

What are the common drug interactions of Cipro and Darzalex, by gender? *:

female:

White blood cell count decreased
Asthenia (weakness)
Platelet count decreased
Weight decreased
Febrile neutropenia (fever with reduced white blood cells)
Pneumonia
Anaemia (lack of blood)
Diarrhoea
Drug intolerance (drug sensitivity)
Facial paralysis (loss of function of face muscle)

male:

Fatigue (feeling of tiredness)
Neuropathy peripheral (surface nerve damage)
Eye swelling
Gait disturbance
Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
Intervertebral disc protrusion (spinal disc protrusion)
Irritability
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Pain

What are the common drug interactions of Cipro and Darzalex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Pneumonia
Plasma cell myeloma (cancer that begins in plasma cells)

60+:

Fatigue (feeling of tiredness)
Influenza
Gait disturbance
Infusion related reaction
Intervertebral disc protrusion (spinal disc protrusion)
Irritability
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Pain of skin
Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 28 people, 100.00%
Pain: 2 people, 7.14%
High Blood Pressure: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Darzalex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously